
    
      The ALIGN study is a single arm, prospective study. The objective of the study is to
      investigate the safety and performance of a catheter-based plication device intended to
      reduce the circumference of the dilated mitral valve. The study will enroll up to 50 subjects
      from up to 5 sites (Paraguay, Columbia, Dominican Republic, Brazil, and India) who will be
      followed for 36 months post index procedure. Enrollment is defined at the time the study
      device is inserted into the body and patients will be followed at 30 days, and Months 6, 12,
      24 and 36 post index procedure.
    
  